SIGRID THERAPEUTICS
Dead / Abandoned — Abandoned — no statement of use filed (as of 20 Nov 2023)
What this means for you
This application is over — abandoned 20 Nov 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88873084
- Mark type
- Stylized text
- Filed
- 15 Apr 2020
- Published for opposition
- 25 Aug 2020
- Abandoned
- 20 Nov 2023
- Attorney of record
- Bradley L. Cohn
Goods and services
- Class 005 — Pharmaceuticals: Dietetic preparations adapted for medical use; dietetic substances in the nature of tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions adapted for medical use; pharmaceuticals and natural remedies for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; preparations for use in naturopathy for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; nutritional supplements; chemical preparations for medical purposes for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; pharmaceutical preparations and chemico- pharmaceutical preparations for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; dietary and nutritional supplements; health food supplements for persons with special dietary requirements; chemical preparations for pharmaceutical purposes for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; pharmaceutical preparations and substances for glycemic control; pharmaceutical preparations and substances for the prevention and treatment of prediabetes, diabetes and for the improvement of overall metabolic health; dietetic preparations and substances for glycemic control; dietetic preparations and substances for the prevention and treatment of prediabetes, diabetes and for the improvement of overall metabolic health; dietary and nutritional supplements for glycemic control; dietary and nutritional supplements for the prevention and treatment of prediabetes, diabetes and for the improvement of overall metabolic health; pharmaceutical preparations in the form of tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions for use in glycemic control; pharmaceutical preparations in the form of tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions for use in the prevention and treatment of prediabetes, diabetes and for the improvement of overall metabolic health; pharmaceutical preparations and substances, dietary and nutritional substances in the form of tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions, all for use in the treatment and regulation of obesity, body weight, body fat, body composition, body weight circumference, cholesterol and LDL cholesterol levels, liver disease, steatohepatitis, infantile colic, gut microbiota, insulin levels and resistance, blood lipids, diarrhea, constipation, colitis; pharmaceutical preparations and substances, dietary and nutritional substances in the form of tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions, all for use in the treatment and regulation of intestinal injury or inflammation, Crohn's disease, cardiovascular risk factors, post bariatric surgery patients, and not including products primarily for use in the treatment of angina pectoris and high blood pressure
- Class 010 — Medical apparatus: Surgical and medical devices for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; capsulated medical devices for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; medical devices for the treatment and prevention of obesity and being overweight, and for use in weight control; medical devices for the treatment and prevention of prediabetes, diabetes and glycemic control, and for the improvement of overall metabolic health; medical devices for use in the prevention and treatment of prediabetes and diabetes; orally administered medical devices for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; surgical and medical devices, capsulated devices and orally administered medical devices all for use in the treatment and regulation of obesity, body weight, body fat, body composition, body weight circumference, cholesterol and LDL cholesterol levels, liver disease, steatohepatitis, infantile colic, gut microbiota, insulin levels and resistance, blood lipids, diarrhea, constipation, intestinal injury or inflammation, colitis, Crohn's disease, cardiovascular risk factors, post bariatric surgery patients
Owner
- Sigrid Therapeutics AB, Solna, SE
- Sigrid Therapeutics AB, Solna, SE
Prosecution history
- 20 Nov 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 20 Nov 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 15 Mar 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Mar 2023 — SOU EXTENSION 5 GRANTED
- 02 Mar 2023 — SOU EXTENSION 5 FILED
- 14 Mar 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 02 Mar 2023 — SOU TEAS EXTENSION RECEIVED
- 10 Sept 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Sept 2022 — SOU EXTENSION 4 GRANTED
- 08 Sept 2022 — SOU EXTENSION 4 FILED
- 08 Sept 2022 — SOU TEAS EXTENSION RECEIVED
- 09 Feb 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Feb 2022 — SOU EXTENSION 3 GRANTED
- 07 Feb 2022 — SOU EXTENSION 3 FILED
- 07 Feb 2022 — SOU TEAS EXTENSION RECEIVED